**Multiple U.S. IPOs are scheduled to price and begin trading in the final week of September 2026, including Oura (targeting up to $2.1 billion), Accelevation Holdings ($660 million range), ADARx Pharmaceuticals ($350 million), and Bamboo Insurance Services ($665 million).** This follows a robust 2026 market that has already seen SpaceX’s record June debut and dozens of other listings, with 280+ offerings completed year-to-date amid improved risk appetite and equity valuations. The active pipeline, supported by recent S-1 filings and 424B4 prospectuses, reflects favorable monetary conditions and sector momentum in tech, healthcare, and insurance. Key near-term catalysts include the September 24–30 pricing windows and any follow-on announcements from high-profile names still targeting 2027. Trader sentiment on near-term completions is shaped by execution risk around valuation and market volatility rather than a lack of candidates.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedDiscord IPO probability collapses amid regulatory delays and market uncertainty
Discord plunges to 11%18%
Discord's expected IPO timeline shifted from early 2026 to mid-2027 due to SEC backlog and valuation concerns, causing market probabilities for a 2026 IPO to collapse and delaying its public debut.

































Beware of external links.
Beware of external links.
Frequently Asked Questions